A large multicenter cohort study was conducted to validate findings from the earlier E-ROP study, which found that no infants who had a birth weight >750 g and were born at or after 27 weeks’ gestational age developed new treatable retinopathy of prematurity (ROP) after 37 weeks’ gestational age. Source: AAO
Real-world study data indicate that when compared with traditional trabeculectomy, PreserFlo MicroShunt implantation leads to better visual outcomes and fewer complications. Source: AAO
A robotic eye examination system is in development, topical anti-hypertensives for glaucoma may cause dry eye, a treatment for pharmacologically induced mydriasis is approved, and bariatric surgery does not increase diabetic retinopathy risk. Source: AAO
With few adverse side effects reported and significant reductions in geographic atrophy seen, avacincaptad pegol may help minimize central vision loss due to age-related macular degeneration (AMD). Source: AAO
Results from a retrospective cohort study found that patients treated by female surgeons had lower rates of adverse postoperative outcomes, including death, than patients treated by male surgeons. Source: AAO
A patient positioning study using head-mounted sensors suggests that minimizing preoperative head movement could slow the progression of fovea-on rhegmatogenous retinal detachment (RRD). Source: AAO
The IRIS Registry provides a broad array of ophthalmology patient information. In this study, investigators leveraged that information to investigate demographic factors that increase the risk of thyroid eye disease (TED). Source: AAO
New-onset AMD occurs after treatment with certain antibiotics, the inventors of OCT receive the 2023 Lasker Award, older patients with glaucoma don’t have reduced general quality of life, and some outcomes in neovascular AMD were affected by pandemic-related delayed care. Source: AAO
In children, using adjustable-focus spectacles for self-refraction was found to be noninferior to other types of autorefraction. Source: AAO
Internal limiting membrane (ILM) flaps show reasonable anatomic closure and visual improvements for the treatment of macular telangiectasia type 2 (MacTel) macular holes. Source: AAO